Description

Kietiburanakul et al developed a score for predicting the risk of an HIV-positive patient developing a skin rash in association with nevirapine therapy. An alternative drug may be considered for a patient who has high risk for developing a rash with nevirapine The authors are from Mahidol University in Bangkok, Thailand.


 

Patient selection: HIV-positive patient with low CD4 count treated with nevirapine in a resource limited setting

 

Parameters:

(1) history of drug allergy

(2) body weight in kilograms

(3) dose escalation regimen

(4) number of concomitant drugs (type not defined)

 

Parameter

Finding

Points

history of drug allergy

no

0

 

yes

14

body weight in kilograms

<= 55 kg

7

 

> 55 k

0

dose escalation

slow

0

 

not slow

7

number of concomitant drugs

0

9

 

1 or more

0

 

total score =

= SUM(points for all 4 parameters)

 

Interpretation:

• minimum score: 0

• maximum score 37

• A score >= 21 identifies a patient at high risk for developing a rash (odds ratio 4).

• A positive score is achieved with history of drug allergy and at least one other risk factor OR the 3 risk factors other than history of drug allergy.

 

Perfromance:

• The specificity of a positve score was 99% with a positive predictive value of 69%. The sensitivity was not given but it is very low if read from Figure 1.

• The area under the ROC curve was 0.71 which is mediocre.

 


To read more or access our algorithms and calculators, please log in or register.